No Prescription |
 |
 | ||
|
Latim Xalacom |
|
| ||
No Prescription » Prescription Drugs 10 » Latim Xalacom Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g. ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.Timolol is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g. ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.Apply this medication in the affected eye(s) usually once daily in the evening or as directed by your doctor. Do not use this medication more frequently than prescribed; using more can decrease effectiveness.To apply eye drops wash your hands first. To avoid contamination do not touch the dropper tip or let it touch your eye or any other surface.The preservative in this product may be absorbed by contact lenses. If you wear contact lenses remove them before using this medication and keep them out of your eyes for at least 15 minutes after applying latanoprost.Tilt your head back look upward and pull down the lower eyelid to make a pouch. Hold the dropper directly over your eye and apply the prescribed number of drops. Look downward and gently close your eye for 1 to 2 minutes. Place one finger at the inside corner of your eye near the nose and apply gentle pressure. This will prevent the medication from draining out. Try not to blink and do not rub your eye.Do not rinse the dropper. Replace the dropper cap after each use.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time each day. It is important to continue using latanoprost even if you feel well. Most people with glaucoma or high pressure in the eye do not feel sick.If you are using another kind of eye medication (e.g. drops or ointments) wait at least 5 minutes before applying other products. Use eye drops before eye ointments to allow the eye drops to enter the eye.Treatment: Closed Angle Glaucoma High Eye Pressure or Glaucoma that May Worsen without Treatment Increased Pressure in the Eye in the Absence of a Lens Increased Eye Pressure caused by Another Disease Buy Latim Xalacom and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Latim Xalacom: Product Type: Prescription Drugs 10 Latim ( Xalacom Generic Latanoprost/Timolol ) Latim (Xalacom Generic Latanoprost/Timolol) Xalacom Generic Latanoprost/Timolol 2.5ml Eye Drops Xalacom Generic Latanoprost/Timolol Latim
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
